Detalhe da pesquisa
1.
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
Headache
; 64(5): 469-481, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706199
2.
Prevalence and burden of migraine in the United States: A systematic review.
Headache
; 64(5): 516-532, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700185
3.
Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States.
Headache
; 64(4): 361-373, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38523435
4.
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine.
Headache
; 64(2): 156-171, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235605
5.
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse.
J Headache Pain
; 25(1): 26, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38408888
6.
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
Cephalalgia
; 43(6): 3331024231180611, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314231
7.
Harassment in the headache field: a global web-based cross-sectional survey.
Cephalalgia
; 43(8): 3331024231193099, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652444
8.
Longitudinal assessment of comorbidities and co-occurring conditions in adolescents with migraine: A secondary analysis of the National Longitudinal Study of Adolescent to Adult Health (Add Health).
Headache
; 63(2): 243-254, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794298
9.
Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial.
Headache
; 63(2): 264-274, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633219
10.
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study.
Headache
; 63(5): 683-691, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797223
11.
Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
Headache
; 63(10): 1448-1457, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795746
12.
Priority acute and preventive migraine treatment benefits: Results of the Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people living with migraine.
Headache
; 63(7): 953-964, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140142
13.
Patient-reported experiences with migraine-related cognitive symptoms: Results of the MiCOAS qualitative study.
Headache
; 63(3): 441-454, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905166
14.
The Exploration of Cannabis and Cannabinoid Therapies for Migraine.
Curr Pain Headache Rep
; 27(9): 339-350, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515745
15.
Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.
J Headache Pain
; 24(1): 151, 2023 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37940856
16.
Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment.
J Headache Pain
; 24(1): 115, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37612633
17.
Migraine: integrated approaches to clinical management and emerging treatments.
Lancet
; 397(10283): 1505-1518, 2021 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773612
18.
Migraine: epidemiology and systems of care.
Lancet
; 397(10283): 1485-1495, 2021 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773613
19.
What do people want to know about "Growing Up with Migraine"? Results of a preference survey of people with lived experience to guide future research.
Cephalalgia
; 42(3): 262-265, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404251
20.
Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
Cephalalgia
; 42(1): 20-30, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644189